Literature DB >> 2552652

Nucleolar grading of breast cancer. Comparative studies on frequency and localization of nucleoli and histology, stage, hormonal receptor status and lectin histochemistry.

B Helpap1.   

Abstract

The localization and number of nucleoli of tumour nuclei were examined after conventional histological typing of breast carcinomas (WHO classification), staging, biochemical receptor status, and lectin binding site histochemistry. With increasing histological atypia and grade of malignancy, the frequency of nucleoli increased significantly and their location shifted from the center to the nuclear periphery. These changes correlated with an increase in indices of mitosis and cell loss. The nucleolar size correlated with the increase in the grade of malignancy. Hormone receptor and lectin binding site positive carcinomas were characterized by a low nucleolar frequency and by small nucleoli in central position, whereas carcinomas with high grades of malignancy and negative hormone receptor and lectin binding site status showed large, often multiple nucleoli in eccentrical position at a high frequency. The studies have demonstrated that nucleolar status is an easily practicable histological/cytological method for use in the assessment of prognosis of carcinomas of the breast.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2552652     DOI: 10.1007/BF00718643

Source DB:  PubMed          Journal:  Virchows Arch A Pathol Anat Histopathol        ISSN: 0174-7398


  44 in total

1.  Nucleolar organizer regions in lymphomas.

Authors:  J Crocker; P Nar
Journal:  J Pathol       Date:  1987-02       Impact factor: 7.996

2.  Evaluation of nucleolar organizer region-associated proteins in breast malignancy.

Authors:  R Smith; J Crocker
Journal:  Histopathology       Date:  1988-02       Impact factor: 5.087

3.  Relationships of S-phase fraction of breast carcinoma in relapse to duration of remission, estrogen receptor content, therapeutic responsiveness, and duration of survival.

Authors:  J S Meyer; J Y Lee
Journal:  Cancer Res       Date:  1980-06       Impact factor: 12.701

4.  Evaluation of estrogen receptors by immunocytochemistry on fine-needle aspiration biopsy specimens from breast tumors.

Authors:  J Weintraub; D Weintraub; M Redard; P Vassilakos
Journal:  Cancer       Date:  1987-09-15       Impact factor: 6.860

5.  Relationship between estrogen receptor concentration and cytomorphometry in breast cancer.

Authors:  A Guazzi; C Bozzetti; M I Riva; D Zaffe; G Cocconi
Journal:  Cancer       Date:  1985-10-15       Impact factor: 6.860

6.  Tumor marker expression in breast carcinomas and relationship to prognosis. An immunohistochemical study.

Authors:  A K Lee; P P Rosen; R A DeLellis; P E Saigo; M D Gangi; S Groshen; R Bagin; H J Wolfe
Journal:  Am J Clin Pathol       Date:  1985-12       Impact factor: 2.493

7.  A comparison of nucleolar organizer region staining and Ki-67 immunostaining in non-Hodgkin's lymphoma.

Authors:  P A Hall; J Crocker; A Watts; A G Stansfeld
Journal:  Histopathology       Date:  1988-04       Impact factor: 5.087

8.  Correlation of cell-cycle kinetics, hormone receptors, histopathology, and nodal status in human breast cancer.

Authors:  R E Moran; M M Black; L Alpert; M J Straus
Journal:  Cancer       Date:  1984-10-15       Impact factor: 6.860

9.  Estrogen and progesterone receptors in breast carcinoma: correlations with epidemiology and pathology.

Authors:  M L Lesser; P P Rosen; R T Senie; K Duthie; C Menendez-Botet; M K Schwartz
Journal:  Cancer       Date:  1981-07-15       Impact factor: 6.860

10.  Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years.

Authors:  H J BLOOM; W W RICHARDSON
Journal:  Br J Cancer       Date:  1957-09       Impact factor: 7.640

View more
  6 in total

1.  Image analysis of the AgNOR response in ras-transformed human breast epithelial cells.

Authors:  Maria Luiza S Mello; Benedicto C Vidal; Jose Russo; Wolfgang Planding; Ulrich Schenck
Journal:  Acta Histochem       Date:  2007-12-26       Impact factor: 2.479

2.  Nucleolar function and size in cancer cells.

Authors:  M Derenzini; D Trerè; A Pession; L Montanaro; V Sirri; R L Ochs
Journal:  Am J Pathol       Date:  1998-05       Impact factor: 4.307

3.  Nucleolar and argyrophilic nucleolar organizer region counts in urothelial carcinomas with special emphasis on grade II tumors.

Authors:  B Helpap; L Loesevitz; A Bulatko
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

4.  Relationship between interphase AgNOR distribution and nucleolar size in cancer cells.

Authors:  M Derenzini; F Farabegoli; D Trerè
Journal:  Histochem J       Date:  1992-12

5.  Prognostic value of proliferating cell nuclear antigen and c-erbB-2 compared with conventional histopathological factors in breast cancer.

Authors:  I Schönborn; W Zschiesche; C Minguillon; E Spitzer; M Möhner; K Ebeling; R Grosse
Journal:  J Cancer Res Clin Oncol       Date:  1995       Impact factor: 4.553

6.  PPM1D controls nucleolar formation by up-regulating phosphorylation of nucleophosmin.

Authors:  Yuuki Kozakai; Rui Kamada; Junya Furuta; Yuhei Kiyota; Yoshiro Chuman; Kazuyasu Sakaguchi
Journal:  Sci Rep       Date:  2016-09-13       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.